QubioTech

A Coruna, Spain Founded: 2014 • Age: 12 yrs
Neuroimage processing software is developed for brain disease detection.

About QubioTech

QubioTech is a company based in A Coruna (Spain) founded in 2014 by Pedro Arenas Barreiro. QubioTech has raised $860.7 thousand across 3 funding rounds from investors including European Union and Nowture. QubioTech offers products and services including Neurocloud, Neurocloud PET, Neurocloud SISCOM, Neurocloud VOL, and Neurocloud SPECT. QubioTech operates in a competitive market with competitors including Qure.ai, Subtle Medical, Perspectum, Zebra Medical Vision and Invicro, among others.

  • Headquarter A Coruna, Spain
  • Founders Pedro Arenas Barreiro
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website qubiotech.com
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $860.7K (USD)

    in 3 rounds

  • Latest Funding Round
    $538.38K (USD), Seed

    May 2023

  • Investors

Products & Services of QubioTech

QubioTech offers a comprehensive portfolio of products and services, including Neurocloud, Neurocloud PET, Neurocloud SISCOM, Neurocloud VOL, and Neurocloud SPECT.

Neurocloud
Neuroimage Processing Platform

Platform for automatic analysis and quantification of brain images.

Neurocloud PET
PET Image Analysis

Tool for detecting metabolism abnormalities in PET scans.

Neurocloud SISCOM
SPECT Analysis

Service for locating epileptic foci using SPECT images.

Neurocloud VOL
Volumetric Analysis

Analyzes atrophy and lesions in MRI scans.

Neurocloud SPECT
DaT-SPECT Tool

Quantifies dopamine transporter for Parkinson's diagnosis.

Funding Insights of QubioTech

QubioTech has successfully raised a total of $860.7K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $538.38 thousand completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $860,695
  • Total Rounds 3
  • Last Round Seed β€” $538,375
  • First Round $58,340

    (Jun 2018)

  • Investors Count 2

All 3 funding rounds of QubioTech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2023$538,375Seed––
Jun 2019$322,320Seed––
–
Jun 2018$58,340Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in QubioTech

QubioTech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and Nowture.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Nowture is engaged in building ventures in life sciences.
–nowture.bioSantiago de Compostela, Spain
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for QubioTech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of QubioTech

1 people are tracked at QubioTech (1 in leadership).

NameRoleGroup
Pedro Arenas Barreiro
Co-Founder & CEOLeadership
Premium access

Complete people profiles for QubioTech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of QubioTech

3 dated milestones of QubioTech across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded QubioTech is founded.
  2. Funding First funding round of $58K.
  3. Funding Latest funding round, Seed, of $538K.

Competitors of QubioTech

QubioTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Qure.ai, Subtle Medical, Perspectum, Zebra Medical Vision and Invicro, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
qure.ai2016Mumbai, India$122.66M240
AI-powered solutions for medical imaging diagnostics
subtlemedical.com2017Palo Alto, United States$18.3M23
AI-driven solutions for medical diagnostic imaging are developed.
perspectum.com2012Oxford, United Kingdom$95.94M196
Precision medicine software for liver disease diagnosis is offered.
zebra-med.com2014Shoham, Israel$50M–
Provider of AI and SaaS-based medical image based decision support tools
invicro.com2008Boston, United States$45.84M308
Provide contract research imaging services and software
arterys.com2012San Francisco, United States$70.2M20
SaaS analytics platform for Medical Image Analysis
vuno.co2014Seoul, South Korea$12M–
AI-based medical image analysis software is developed for healthcare providers.
icometrix.com2011Leuven, Belgium$20.18M37
AI-based software for brain MRI analysis is provided by icometrix.
vara.ai2016Berlin, Germany$20.33M26
Provider of AI-based breast cancer screening software for clinics
Premium access

Detailed competitors of QubioTech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to QubioTech

10 companies that operate in the same segment as QubioTech (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 713.57 M––
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M233
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M––
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 508.73 M––
App-based health insurance is offered to individuals and businesses.
2016Paris, FranceUSD 863.12 M––
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M–
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M––
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about QubioTech

QubioTech was founded in 2014 and raised its 1st funding round 4 years after it was founded.

QubioTech is headquartered in A Coruna, Spain. It is registered at A Coruna, Galicia, Spain.

Pedro Arenas Barreiro is the current CEO of QubioTech. They have also founded this company.

QubioTech is a funded company, having raised a total of $860.7K across 3 funding rounds to date. The company's 1st funding round was a Grant of $58.34K, raised on Jun 2018.

QubioTech was founded in 2014 in A Coruna, Spain, as a developer of neuroimage processing software focused on brain disease detection and monitoring. Automatic quantification of biomarkers is enabled in multimodal images from PET, SPECT, and MRI sources. The software integrates with existing systems without installation needs. Calculations of biomarkers are performed, alongside comparisons to databases of healthy controls, supporting clinical operations in the healthcare sector.

QubioTech's top competitors include Perspectum, Qure.ai and Subtle Medical.

QubioTech offers Neurocloud, Neurocloud PET, Neurocloud SISCOM, Neurocloud VOL, and Neurocloud SPECT.

QubioTech has 2 investors. Key investors include European Union, and Nowture.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available